Henry Schein, Inc.
A global distributor supplying office-based dentists and doctors with everything from dental implants and biomaterials to practice-management software and everyday supplies. It grew out of a single New York City pharmacy that founder Henry Schein and his wife Esther opened in 1932 during the Great Depression, later shifting to mail-order medical supplies. In those hard years, Henry kept a notebook behind the counter listing customers who couldn't pay, letting them take medicine on trust—a habit of service that shaped the company's culture.
Granted 206.6K · Sold 149.8K
Granted 20.4K · Sold 5.8K
Granted 2.6K
Granted 81.8K
Granted 80.3K · Sold 12.2K
Granted 80.3K · Sold 8.9K
Granted 95.2K
Granted 60.2K
Granted 67.5K · Sold 1.4K
Granted 12.6K · Sold 21.0K
Granted 23.4K · Sold 21.7K
Granted 8.0K
Granted 19.1K · Sold 4.1K
Granted 5.4K
Granted 8.0K
Granted 7.6K · Bought 20.0K
Granted 8.0K · Sold 9.7K
Granted 8.0K
Granted 7.1K
Granted 8.0K
Granted 8.0K · Sold 7.2K
Granted 8.0K
Granted 8.0K
Granted 8.0K
Granted 8.0K
Granted 5.4K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Bergman Stanley MFormer Director · 43 transactions | -12.8% | 1.31M | 206.6K | — | 149.8K |
| Breslawski James PPresident · 7 transactions | -1.6% | 200.2Kas of Mar 2025 | 20.4K | — | 5.8K |
| Paladino StevenDirector · 3 transactions | +0.2% | 144.9Kas of Mar 2024 | 2.6K | — | — |
| Albertini AndreaCEO, Global Dist. & Tech. · 8 transactions | — | 120.7K | 81.8K | — | — |
| Ettinger Michael SEVP & Chief Operating Officer · 17 transactions | +48.6% | 112.4K | 80.3K | — | 12.2K |
| Mlotek Mark EEVP, Chief Strategic Officer · 18 transactions | +46.8% | 109.9K | 80.3K | — | 8.9K |
| Lowery Frederick M.CEO, Director · 2 transactions | — | 95.2K | 95.2K | — | — |
| South Ronald N.SVP & Chief Financial Officer · 9 transactions | +75.3% | 88.9K | 60.2K | — | — |
| Popeck Thomas CCEO, Henry Schein Products · 8 transactions | — | 86.2K | 67.5K | — | 1.4K |
| McGlynn LoreleiSVP, Chief Human Res. Officer · 3 transactions | -14.9% | 72.3Kas of Sep 2024 | 12.6K | — | 21.0K |
| Connett Bradford CCEO, NA Distribution Group · 7 transactions | -12.5% | 62.7Kas of Mar 2025 | 23.4K | — | 21.7K |
| Sheares Bradley TDirector · 5 transactions | +17.1% | 47.6K | 8.0K | — | — |
| Siegel WalterSr. VP & Chief Legal Officer · 6 transactions | +20.9% | 43.2Kas of Mar 2025 | 19.1K | — | 4.1K |
| Raphael CarolDirector · 4 transactions | +14.5% | 33.5Kas of May 2025 | 5.4K | — | — |
| Herring Joseph LDirector · 3 transactions | +36% | 30.3K | 8.0K | — | — |
| Daniel William KDirector · 5 transactions | — | 27.6K | 7.6K | 20.0K | — |
| Laskawy Philip ADirector · 6 transactions | -6.5% | 24.5K | 8.0K | — | 9.7K |
| Margulies Anne H.Director · 8 transactions | +27.4% | 23.2K | 8.0K | — | — |
| Sheehy Christine ZayacSVP, Chief Human Res. Officer · 4 transactions | — | 18.5K | 7.1K | — | — |
| Derby DeborahDirector · 3 transactions | +102.5% | 15.9K | 8.0K | — | — |
| Kuehn Kurt PDirector · 8 transactions | -1.6% | 15.4K | 8.0K | — | 7.2K |
| Ali MohamadDirector · 4 transactions | +97.8% | 15.1K | 8.0K | — | — |
| Tuckson Reed VaughnDirector · 6 transactions | +107% | 12.5K | 8.0K | — | — |
| Serota Scott PhilipDirector · 5 transactions | +144% | 11.8K | 8.0K | — | — |
| Faig Carole TDirector · 3 transactions | — | 8.0K | 8.0K | — | — |
| Hombach Robert J.Director · 2 transactions | — | 5.4K | 5.4K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 3 years: -222.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.